A new study has found that the ferritin-to-albumin ratio (FAR), a biomarker that reflects both inflammation and nutritional status, can predict short-term mortality in critically ill patients with non-COVID-19 pneumonia. The research, published in Respiratory Medicine (Feng et al., 2025), analyzed data from 827 patients admitted with pneumonia to the intensive care unit. This could aid in early risk stratification, helping identify patients who may need closer monitoring or more aggressive treatment. Ferritin-to-Albumin Ratio Predicts Short-Term Mortality in Critically Ill Patients with Non-COVID-19 Pneumonia: A Retrospective Cohort Study from MIMIC-IV database. https://doi.org/10.1016/j.rmed.2025.108361Keywords: ferritin-to-albumin ratio, non-COVID-19 pneumonia, inflammation, nutrition, mortality risk, intensive care, prognostic biomarker.